Company / Cash per Share
Zenas BioPharma, Inc. Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.65
FY2025
5-year range
$2.65 / $202.77
FY2023-FY2025
Trend
-98.7%
vs FY2024
Sector context
#80 of 205
Health Care
What the data says
At $2.65, Zenas BioPharma, Inc.'s cash per share ranks #80 of 205 in the Health Care sector. Declined from $37.13 to $2.65 over the past 2 years.
Based on SEC 10-K filings.
2.65 in FY2025.
Declined from $37.13 to $2.65 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#80 of 205 in Health CareTop 39% of 205This company $2.65 Sector average $72.93
▼
-96.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 98.7% year-over-year.
- Ranks #80 out of 205 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.65 | -98.7% |
| FY2024 | $202.77 | +446.1% |
| FY2023 | $37.13 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026